Novabay Pharmaceuticals (NBY)
NYSE MKT:NBY
Holding NBY?
Track your performance easily

NovaBay Pharma (NBY) Financial Statements

637 Followers

NovaBay Pharma Financial Overview

NovaBay Pharma's market cap is currently ―. The company's EPS TTM is $-35.469; its P/E ratio is -0.02; NovaBay Pharma is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 2.44M$ 2.40M$ 2.63M$ 3.73M$ 3.27M
Gross Profit$ 1.59M$ 1.59M$ 1.79M$ 1.81M$ 1.84M
EBIT$ -1.21M$ -1.58M$ -3.21M$ -798.00K$ -1.12M
EBITDA$ -972.00K$ -1.09M$ -2.79M$ -748.00K$ -1.06M
Net Income Common Stockholders$ -1.21M$ -1.58M$ -3.59M$ -9.17M$ -1.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 776.00K$ 751.00K$ 1.82M$ 3.13M$ 3.47M
Total Assets$ 3.88M$ 3.92M$ 5.36M$ 9.03M$ 12.85M
Total Debt$ 1.26M$ 2.01M$ 2.42M$ 2.74M$ 3.00M
Net Debt$ 486.00K$ 1.26M$ 600.00K$ -390.00K$ -473.00K
Total Liabilities$ 2.81M$ 4.54M$ 5.20M$ 5.72M$ 5.82M
Stockholders Equity$ 1.07M$ -617.00K$ -1.28M$ 3.31M$ 7.04M
Cash Flow-
Free Cash Flow$ -2.06M$ -580.00K$ -1.57M$ -316.00K$ -365.00K
Operating Cash Flow$ -2.06M$ -578.00K$ -1.57M$ -314.00K$ -363.00K
Investing Cash Flow$ -2.00K$ -2.00K$ 1.07M$ -2.00K$ -2.00K
Financing Cash Flow$ 2.09M$ -492.00K$ -597.00K$ -26.00K$ -577.00K
Currency in USD

NovaBay Pharma Earnings and Revenue History

NovaBay Pharma Debt to Assets

NovaBay Pharma Cash Flow

NovaBay Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis